VP Research, Amgen
Philip Tagari is currently Vice President of Research (Therapeutic Discovery) at Amgen Inc, the world’s largest biotechnology company. His global laboratories are responsible for biologics discovery, scaffold engineering, optimization and early manufacturability assessment; medicinal, oligonucleotide and peptide chemistry; protein conjugates (ADC, peptibodies) and reagents; assay development, screening, enzymological and pharmacological characterization and profiling (in vitro), as well as structural biology, biophysics, computational and analytical chemistry, materials logistics and automation. Research labs under his direction have advanced over 30 innovative molecules into clinical development in recent years. Prior to joining Amgen in 1998, Philip was a Research Fellow at Merck Frosst (Canada) Inc. Philip is a graduate of Gonville & Caius College, Cambridge University (UK).